Christopher Stone
2016
In 2016, Christopher Stone earned a total compensation of $1.6M as Vice President, General Counsel and Secretary at PDL BioPharma, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $751,872 |
|---|---|
| Salary | $460,350 |
| Stock Awards | $327,990 |
| Other | $10,000 |
| Total | $1,550,212 |
Stone received $751.9K in non-equity incentive plan, accounting for 49% of the total pay in 2016.
Stone also received $460.4K in salary, $328K in stock awards and $10K in other compensation.
Rankings
In 2016, Christopher Stone's compensation ranked 6,087th out of 14,075 executives tracked by ExecPay. In other words, Stone earned more than 56.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,087 out of 14,075 | 57th |
Division Manufacturing | 2,217 out of 5,488 | 60th |
Major group Chemicals And Allied Products | 725 out of 1,900 | 62nd |
Industry group Drugs | 547 out of 1,543 | 65th |
Industry Biological Products, Except Diagnostic Substances | 104 out of 287 | 64th |
Source: SEC filing on April 28, 2017.
Stone's colleagues
We found four more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2016.